Zeng, Feier
Carrasco, Giovana
Li, Boya
Sophocleous, Antonia
Idris, Aymen I.
Article History
Received: 6 October 2022
Accepted: 14 March 2023
First Online: 21 March 2023
Competing interests
: A.I. Idris is an inventor on a patent concerning the use of NFκB inhibitors for the treatments of bone diseases. Other authors declare no conflict of interest.